Supplementary Table S1 from Targeting Activating Transcription Factor 3 by Galectin-9 Induces Apoptosis and Overcomes Various Types of Treatment Resistance in Chronic Myelogenous Leukemia

MLA

Masafumi Taniwaki, et al. Supplementary Table S1 from Targeting Activating Transcription Factor 3 by Galectin-9 Induces Apoptosis and Overcomes Various Types of Treatment Resistance in Chronic Myelogenous Leukemia. Apr. 2023. EBSCOhost, https://doi.org/10.1158/1541-7786.22518723.v1.

APA

Masafumi Taniwaki, Mitsuomi Hirashima, Akira Yamauchi, Shinya Kimura, Shigeo Horiike, Yuji Shimura, Nana Sasaki, Tsutomu Kobayashi, Hisao Nagoshi, Mio Yamamoto, & Junya Kuroda. (2023). Supplementary Table S1 from Targeting Activating Transcription Factor 3 by Galectin-9 Induces Apoptosis and Overcomes Various Types of Treatment Resistance in Chronic Myelogenous Leukemia. https://doi.org/10.1158/1541-7786.22518723.v1

Chicago

Masafumi Taniwaki, Mitsuomi Hirashima, Akira Yamauchi, Shinya Kimura, Shigeo Horiike, Yuji Shimura, Nana Sasaki, et al. 2023. “Supplementary Table S1 from Targeting Activating Transcription Factor 3 by Galectin-9 Induces Apoptosis and Overcomes Various Types of Treatment Resistance in Chronic Myelogenous Leukemia,” April. doi:10.1158/1541-7786.22518723.v1.